Latest News about ALNY
Recent news which mentions ALNY
From Benzinga
Looking Into Alnylam Pharmaceuticals's Return On Capital Employed
February 11, 2022
Tickers
ALNY
From Benzinga
Alnylam Clocks 76% Increase In Q4 Product Sales, Expects FY22 Product Sales Of Up To $1B
February 10, 2022
From Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
From Benzinga
Earnings Scheduled For February 10, 2022
February 10, 2022
From Benzinga
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
From MarketWatch
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022
February 03, 2022
From Benzinga
A Bearish Sign Appears On Alnylam Pharmaceuticals's Chart
January 21, 2022
Tickers
ALNY
From Benzinga
The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective
January 21, 2022
From Benzinga
What 10 Analyst Ratings Have To Say About Alnylam Pharmaceuticals
January 20, 2022
Tickers
ALNY
From Benzinga
The Week Ahead In Biotech (Jan 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week
January 16, 2022
From Benzinga
3 Can't-Miss Biotech Events Coming Up in 2022
January 07, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
January 03, 2022
From Benzinga
What 9 Analyst Ratings Have To Say About Alnylam Pharmaceuticals
January 03, 2022
Tickers
ALNY
From Benzinga
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
December 31, 2021
From Benzinga
51 Biggest Movers From Yesterday
December 28, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 27, 2021
From Benzinga
34 Stocks Moving In Monday's Mid-Day Session
December 27, 2021
From Benzinga
FDA Approves Alnylam - Novartis' Leqvio As the First siRNA To Reduce Bad Cholesterol
December 23, 2021
From Benzinga
The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review
December 23, 2021
From Benzinga
From Benzinga
2 Mid-Cap Biopharma Stocks BofA Securities Recommends For 2022
December 14, 2021
From Benzinga
3 Under-the-Radar Biotech Stocks to Buy in 2022
December 11, 2021
From Motley Fool
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
Why Arbutus Biopharma Is Rocketing Higher Today
December 01, 2021
From Motley Fool
4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout
November 23, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free